Generation and functional characterization of mouse monocyte-derived dendritic cells

European Journal of Immunology

Volumn 29, Issue 9, 1999, Pages 2835-2841

  Schreurs, Marco W J ^a   Eggert, Andreas A O ^a   De Boer, Annemiek J ^a   Figdor, Carl G ^a   Adema, Gosse J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Dendritic cell; GM CSF; IL 4; Monocyte; Mouse

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ANIMAL CELL; ANTIGEN PRESENTATION; ARTICLE; BONE MARROW; CELL STRUCTURE; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; IMMUNOSTIMULATION; MALE; MONOCYTE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL;

EID: 0033368284     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1521-4141(199909)29:09<2835::aid-immu2835>3.0.co;2-q     Document Type: Article

References (26)

1. Hart, D. N., Dendritic cells: unique leukocyte populations which control the primary immune réponse. Blood 1997.90:3245-3287.
2. Mayordomo, J. I., Zorina, T., Storkus, W. J., Zitvogel, L., Celluzzi, C., Falo, L. D., Melief, C. J., lldstad, S. T., Käst, W. M., Deleo, A. B. and Lotze, M. T., Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity. Nat. Med. 1995.1:1297-1302.
3. Boczkowski, D., Nair, S. K., Snyder, D. and Gilboa, E., Dendritic cells pulsed with RNA are potent antigenpresenting cells in vitro and in vivo. J. Exp. Med. 1996. 184: 465-472.
4. Fields, R. C., Shimizu, K. and Mule, J. J., Murine dendritic cells pulsed with whole tumor lysates mediate potent antitumor immune responses in vitro and in vivo. Proc. Natl. Acad. Sei. USA 1998. 95: 9482-9487.
5. Sallusto, F. and Lanzavecchia, A., Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colonystimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med. 1994.179: 1109-1118.
6. Romani, N., Grüner, S., Brang, D., Kampgen, E., Lenz, A., Trockenbacher, B., Konwalinka, G., Fritsch, P. O., Steinman, R. M. and Schuler, G., Proliferating dendritic cell progenitors in human blood. J. Exp. Med. 1994.180: 83-93.
7. Caux, C., Vanbervliet, B., Massacrier, C., Dezutterdambuyant, G., Desaintvis, B., Jacquet, G., Yoneda, K., Imamura, S., Schmitt, D. and Banchereau, J., CD34(+) hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF + TNF alpha. J. Exp. Med. 1996.184:695-706.
8. Inaba, K., Inaba, M., Romani, N., Aya, H., Deguchi, M., Ikehara, S., Muramatsu, S. and Steinman, R. M., Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/ macrophage colony-stimulating factor. J. Exp. Med. 1992.176:1693-1702.
9. Maldonado-Lopez, R., DeSmedt, T., Michel, P., Godfroid, J., Pajak, B., Heirman, C., Thielemans, K., Leo, O., Urbain, J. and Moser, M., CD8a+ and CDSctsubclasses of dendritic cells direct the development of distinct T helper cells in vivo. J. Exp. Med. 1999. 189: 587-592.
10. Rissoan, M. C., Soumelis, V., Kadowaki, N., Grouard, G., Briere, F., de Waal Malefyt, R. and Liu, Y. J., Reciprocal control of T helper cell and dendritic cell differentiation. Science 1999. 283:1183-1186.
11. Pulendran, B., Smith, J. L., Caspary, G., Brasel, K., Pettit, D., Maraskovsky, E. and Maliszewski, C. R., Distinct dendritic cell subsets differentially regulate the class of immune response in vivo. Proc. Nail. Acad. Sei. USA 1999. 96:1036-1041.
12. Mackey, M. F., Gunn, J. R., Maliszewsky, C., Kikutani, H., Noëlle, R. J. and Barth, R. J. Jr., Dendritic cells require maturation via CD40 to generate protective antitumor immunity. J. Immunol. 1998.161: 2094-2098.
13. Garrigan, K., Moroni-Rawson, P., McMurray, C., Hermans, I., Abernethy, N., Watson, J. and Ronchese, F., Functional comparison of spleen dendritic cells and dendritic cells cultured in vitro from bone marrow precursors. Blood 1996. 88: 3508-3512.
14. Winzler, C., Rovere, P., Rescigno, M., Granucci, F., Penna, G., Adorini, L., Zimmermann, V. S., Davoust, J. and Ricciardi-Castagnoli, P., Maturation stages of mouse dendritic cells in growth factor-dependent longterm cultures. J. Exp. Med. 1997. 185: 317-328.
15. Randolph, G. J., Beaulieu, S., Lebecque, E., Steinman, R. M. and Muller, W. A., Differentiation of monocytes into dendritic cells in a model of transendothelial trafficking. Science 1998. 282: 480-483.
16. Bakker, A. B. H., Marland, G., De Boer, A. J., Huijbens, R. J., Dänen, E. H., Adema, G. J. and;Figdor, C. G., Generation of anti-melanoma cytotoxic T lymphocytes from healthy donors after presentation of melanoma-associated antigen-derived epitopes by dendritic cells in vitro. Cancer Res. 1995. 55: 5330-5334.
17. Mortarini, R., Anichini, A., Dinicola, M., Siena, S., Bregni, M., Belli, F., Molla, A., Gianni, A. M. and Parmiani, G., Autologous dendritic cells derived from CD34(+) progenitors and from monoytes are not functionally equivalent antigen-presenting cells in the induction of Melan-A/Mart-1(27-35)-specific CTLs from peripheral blood lymphocytes of melanoma patients with low frequency of CTL precursors. Cancer Res. 1997.57:5534-5541.
18. Raje, N., Gong, J., Chauhan, D., Teoh, G., Avigan, D., Wu, Z., Chen, D., Treon, S. P., Webb, I. J., Kufe, D. W. and Anderson, K. C., Bone marrow and peripheral blood dendritic cells from patients with multiple myeloma are phenotypically and functionally normal despite the detection of Kaposi's sarcoma herpesvirus gene sequences. Blood 1999. 93:1487-1495.
19. Hsu, F. J., Benike, C., Fagnoni, F., Liles, T. M., Czerwinski, D., Taidi, B., Engleman, E. G. and Levy, R., Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nat. Med. 1996.2:52-58.
20. Nestle, F. O., Alijagic, S., Gilliet, M., Sun, Y., Grabbe, S., Dummer, R., Burg, G. and Schadendorf, D., Vaccination of melanoma patients with peptide- or tumor Jysate-pulsed dendritic cells. Nat. Med. 1998. 4: 328-332.
21. Kraal, G., Breel, M., Janse, M. and Bruin, G., Langerhans' cells, veiled cells, and interdigitating cells in the mouse recognized by a monoclonal antibody. J. Exp. Med. 1986.163:981-997.
22. Schreurs, M. W. J., de Boer, A. J., Figdor, C. G. and Adema, G. J., Genetic vaccination against the melanocyte lineage-specific antigen gplOO induces cytotoxic T lymphocyte-mediated tumor protection. Cancer Res. 1998.58:2509-2514.
23. Rolink, A., Melchers, F. and Andersson, J., The SCID but not the RAG-2 gene product is required for S mu-S epsilon heavy chain class switching. Immunity 1996. 5: 319-330.
24. Falk, K., Rötzschke, O., Stevanovic, S., Jung, G. and Rammensee, H. G., Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 1991. 351: 290-296.
25. Traversari, C., van der Bruggen, P., van den Eynde, B., Hainaut, P., Lemoine, C., Ohta, N., Old, L. and Boon, T., Transfection and expression of a gene coding for a human melanoma antigen recognized by autologous cytolytic T lymphocytes. Immunogenetics 1992. 35: 145-152.
26. Falo, L. D. Jr., Kovacsovics-Bankowski, M., Thompson, K. and Rock, K. L., Targeting antigen into the phagocytic pathway in vivo induces protective tumour immunity. Nat. Med. 1995.1: 649-653.